Research ArticleArticle
Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population
Brigitte Michelsen, Andreas P. Diamantopoulos, Hege Kilander Høiberg, Dag Magnar Soldal, Arthur Kavanaugh and Glenn Haugeberg
The Journal of Rheumatology February 2017, jrheum.160973; DOI: https://doi.org/10.3899/jrheum.160973
Brigitte Michelsen
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Andreas P. Diamantopoulos
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Hege Kilander Høiberg
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Dag Magnar Soldal
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Arthur Kavanaugh
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Glenn Haugeberg
From the Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand; Department of Rheumatology, Haugesund Rheumatism Hospital, Haugesund, Norway; Division of Rheumatology, Allergy, Immunology, University of California at San Diego, San Diego, California, USA; Department of Rheumatology, Martina Hansens Hospital, Bærum; Norwegian University of Science and Technology, Trondheim, Norway. Funded by an unrestricted grant from Pfizer (GH). Clinical research fellowship from the Hospital of Southern Norway Trust (BM). B. Michelsen, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A.P. Diamantopoulos, PhD, Department of Rheumatology, Haugesund Rheumatism Hospital; H.K. Høiberg, MD, Department of Rheumatology, Hospital of Southern Norway Trust; D.M. Soldal, MD, Department of Rheumatology, Hospital of Southern Norway Trust; A. Kavanaugh, PhD, Division of Rheumatology, Allergy, Immunology, University of California at San Diego; G. Haugeberg, PhD, Department of Rheumatology, Hospital of Southern Norway Trust, and Department of Rheumatology, Martina Hansens Hospital, and Norwegian University of Science and Technology. Address correspondence to Dr. B. Michelsen, Department of Rheumatology, Hospital of Southern Norway Trust, Service box 416, 4604 Kristiansand, Norway. E-mail: brigitte_michelsen@yahoo.no. Accepted for publication December 5, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population
Brigitte Michelsen, Andreas P. Diamantopoulos, Hege Kilander Høiberg, Dag Magnar Soldal, Arthur Kavanaugh, Glenn Haugeberg
The Journal of Rheumatology Feb 2017, jrheum.160973; DOI: 10.3899/jrheum.160973
Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population
Brigitte Michelsen, Andreas P. Diamantopoulos, Hege Kilander Høiberg, Dag Magnar Soldal, Arthur Kavanaugh, Glenn Haugeberg
The Journal of Rheumatology Feb 2017, jrheum.160973; DOI: 10.3899/jrheum.160973